Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Nature Communications|April 4, 2026
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetesChungsoo Kim, Fan Bu, Clair Blacketer, et al.
BMJ Open|December 23, 2021
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort studyCarlen Reyes, Andrea Pistillo, Sergio Fernández-Bertolín, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studyDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
The Lancet. Digital Health|December 21, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysisDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Korean Journal of Anesthesiology|February 3, 2026
K-MIMIC: a nationwide Korean multi-institutional Multimodal intensive care datasetYoung-Gon Kim, Jongho Shin, Sul Mui Won, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort studyTalita Duarte-Salles, David Vizcaya, Andrea Pistillo, et al.
JMIR Medical Informatics|March 4, 2021
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation StudyJenna M Reps, Chungsoo Kim, Ross D Williams, et al.
Pediatrics|May 29, 2021
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International ExperienceTalita Duarte-Salles, David Vizcaya, Andrea Pistillo, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Pageof 22